JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today that it has entered into Syndicated Credit Facilities totaling $4 billion supporting the $6.8 billion acquisition of Cephalon, Inc. HSBC Bank plc is the Sole Coordinating Bookrunner and Mandated Lead Arranger for the facilities. The syndicate also includes Barclays Capital, BNP Paribas, Citi, Credit Suisse, Goldman Sachs International, J.P. Morgan and Morgan Stanley as Bookrunners and Mandated Lead Arrangers, and Bank Hapoalim, Bank Leumi, DnB NOR Bank, Royal Bank of Canada, Raiffeisen Bank International and UniCredit as Lead Arrangers.
